UnitedHealth Group Inc., an American healthcare company offering a full spectrum of health benefit programs for employers, individuals, and medicaid beneficiaries, has reportedly launched a new benefit program to support overall wellbeing a....

The acquisition agreement is inked at a valuation of USD 106.5 million. Under the agreement, REIT would be able to extend its relationship with prominent grocers in the coming times. Toronto based Slate Retail Real Estate Investment Tr....

Samsung Electronics has introduced its first human-centric LED packages, under the name LM302N. It is believed that the LM302N family tends to help human bodies maintain melatonin levels indoors, thereby making them feel relaxed and exubera....

Digital asset platform Phoenix Lending has recently unveiled its new Stable Income Product with free debit card. This move comes along the heels of the keen participation witnessed by lending products in February 2020. Since the launch on ....

The European Union and the United States are likely to partner to counter the increasing dominance of Chinese tech giant, Huawei Technologies on next generation 5G telecommunications technology. However, this partnership will reportedly onl....

CytoDyn Inc., announced that it has submitted a Phase 2 protocol with the U.S. Food and Drug Administration (FDA) for a basket trial under its cancer IND. The company can instantly start enrollment in this trial to offer therapy for around ....

Pyxus International, Inc., one of the leading value-added agricultural companies in the world, has reportedly collaborated with Turning Point Brands, a leading company in OTP (Other Tobacco Products) and adult consumer alternatives. Source....

Alkahest will initiate Phase 2 trial for AKST4290, an inhibitor to treat Parkinson’s disease The firm has been partly funded by The Michael J. Fox Foundation for the research Alkahest, Inc., a biotech firm involved in the develop....

Moleculin Biotech, Inc., a preclinical pharmaceutical company and developer of anti-cancer drug candidates, has recently announced the completion of its US Phase 1 trial. The open label, single arm clinical trial met its primary objective t....

The threat of coronavirus needs to be addressed as early as possible, particularly since there are no particular treatments or vaccines currently available for patients suffering from coronavirus globally. As the count of patients infected ....